Stocks · Coverage Archive

$CLBT

9.70 ▼ 36.43%

Every Regards of Wallstreet article on $CLBT, newest first — 1 story and counting.

Followed tickers pin their next report date and latest coverage to the homepage and the earnings calendar.

  1. 2026-08-13 · 6 min read

    Why Is Cellebrite (CLBT) Stock Down? A 2.6% Guide Cut and a New CEO

    Cellebrite trimmed its 2026 ARR guide by $15 million, raised its EBITDA target, and replaced CEO Thomas Hogan the same morning. Shares fell 31% pre-market, about $1.2 billion of market value.

New to options? See our plain-English strategy playbook →

The Week-Ahead Brief

Don’t miss next week’s setups. Get the Saturday brief.

Every Saturday: next week’s earnings dates, Fed days and the trades worth watching, from the same desk that writes the week-ahead hub. Free, built for retail investors.

Subscribing means we email you the newsletter and nothing else. No spam, no sharing your address, unsubscribe in one click. See the privacy policy.